Ameriprise Financial Inc Castle Biosciences Inc Transaction History

Ameriprise Financial Inc

  • $381 Billion
  • Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Castle Biosciences Inc stock. As of the latest transaction made, Ameriprise Financial Inc holds 349,229 shares of CSTL stock, worth $10.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
349,229
Previous 294,022 18.78%
Holding current value
$10.8 Million
Previous $6.4 Million 55.63%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$17.4 - $31.47 $960,601 - $1.74 Million
55,207 Added 18.78%
349,229 $9.96 Million
Q2 2024

Aug 14, 2024
SELL
$18.84 - $24.94 $24,586 - $32,546
-1,305 Reduced 0.44%
294,022 $6.4 Million
Q1 2024

May 15, 2024
BUY
$18.06 - $25.3 $281,736 - $394,680
15,600 Added 5.58%
295,327 $6.54 Million
Q4 2023

Feb 14, 2024
BUY
$12.19 - $22.43 $167,332 - $307,896
13,727 Added 5.16%
279,727 $6.04 Million
Q3 2023

Nov 14, 2023
SELL
$13.28 - $20.3 $689,949 - $1.05 Million
-51,954 Reduced 16.34%
266,000 $4.49 Million
Q2 2023

Aug 14, 2023
BUY
$11.66 - $26.0 $2.37 Million - $5.28 Million
203,045 Added 176.7%
317,954 $4.36 Million
Q1 2023

May 15, 2023
BUY
$19.47 - $28.49 $71,454 - $104,558
3,670 Added 3.3%
114,909 $2.61 Million
Q4 2022

Feb 14, 2023
SELL
$18.08 - $30.0 $384,760 - $638,430
-21,281 Reduced 16.06%
111,239 $2.62 Million
Q3 2022

Nov 14, 2022
SELL
$22.51 - $34.32 $622,041 - $948,398
-27,634 Reduced 17.25%
132,520 $3.46 Million
Q2 2022

Aug 15, 2022
BUY
$16.0 - $45.99 $585,376 - $1.68 Million
36,586 Added 29.61%
160,154 $3.52 Million
Q1 2022

May 16, 2022
BUY
$33.17 - $46.98 $472,572 - $669,324
14,247 Added 13.03%
123,568 $5.55 Million
Q4 2021

Feb 14, 2022
BUY
$39.06 - $67.58 $665,348 - $1.15 Million
17,034 Added 18.46%
109,321 $4.69 Million
Q3 2021

Nov 15, 2021
SELL
$60.13 - $77.6 $60,430 - $77,988
-1,005 Reduced 1.08%
92,287 $6.14 Million
Q2 2021

Aug 16, 2021
SELL
$50.07 - $76.78 $789,103 - $1.21 Million
-15,760 Reduced 14.45%
93,292 $6.84 Million
Q1 2021

May 17, 2021
SELL
$58.92 - $97.33 $1.47 Million - $2.43 Million
-24,950 Reduced 18.62%
109,052 $7.47 Million
Q4 2020

Feb 12, 2021
SELL
$43.6 - $73.05 $519,450 - $870,317
-11,914 Reduced 8.16%
134,002 $9 Million
Q3 2020

Nov 16, 2020
BUY
$38.47 - $52.03 $1.81 Million - $2.44 Million
46,923 Added 47.4%
145,916 $7.51 Million
Q2 2020

Aug 14, 2020
BUY
$27.28 - $43.01 $1.66 Million - $2.62 Million
60,993 Added 160.51%
98,993 $3.73 Million
Q1 2020

May 15, 2020
BUY
$23.08 - $35.53 $877,039 - $1.35 Million
38,000 New
38,000 $1.13 Million

Others Institutions Holding CSTL

# of Institutions
200
Shares Held
25.9M
Call Options Held
292K
Put Options Held
30.3K
View Full List

About CASTLE BIOSCIENCES INC

CSTL Quotes by TradingView
  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $811M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email